Infographic: Counterfeiting By The Numbers

January 30, 2020

Our infographic, “Counterfeiting by the Numbers,” highlights facts from the U.S. Department of Homeland Security’s January 2020 report, Combating Trafficking in Counterfeit and Pirated Goods, which documents the extraordinary scale of the global counterfeiting market and its effects across all economic sectors—including medicines.

Read More

PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.

January 29, 2020

The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…

Read More

New Jersey Enacts Increased Penalties for Counterfeit Drug Crimes

January 21, 2020

The Governor of New Jersey has just signed A-5037, a new law designed to increase penalties for counterfeit drug crimes committed in the state.

Read More

Counterfeiter Who Made At Least 4.3 Million Fake Xanax Pills Sentenced

January 17, 2020

The U.S. Department of Justice announced that Stephan Caamano, who manufactured and sold at least 4.3 million counterfeit Xanax pills, will spend the next 13 years in federal prison after pleading guilty to his crimes…

Read More

Canadian health law experts predict: Canada won’t end up as the drugstore to the U.S.

January 16, 2020

This editorial by David C. Rosenbaum and Dara Jospé was published in the Financial Post on January 16, 2020. Rosenbaum is a partner of the law firm Fasken. Jospé is an associate for the same company.

Read More

4-Year-Old Girl Died in September After Swallowing a Fentanyl-Laced Pill. Now Her Caregiver Has Been Charged in Her Death

January 14, 2020

The Maricopa County Medical Examiner has blamed fentanyl poisoning for the death of a four-year-old girl in Glendale last September. The report cited fentanyl toxicity as the cause of the little girl’s death.

Read More

Academic Warns That State Drug Importation Proposals Threaten Patients and Innovation

January 10, 2020

This editorial by Dr. Kristina M. L. Acri née Lybecker was published in IP Watchdog on January 2, 2020. Dr. Acri is an Associate Professor of Economics at Colorado College in Colorado Springs, and Chair of the Department of Economics and Business.

Read More

Doctor in Pennsylvania Pleads Guilty To Treating Patients with Imported Injectable Biologic Medications

December 20, 2019

Dr. Thomas Whalen, a rheumatologist who practiced medicine in Havertown, Pennsylvania has pleaded guilty to charges he purchased non-FDA approved, temperature-sensitive biologic medication from Turkey and the United Kingdom to treat his rheumatology patients.

Read More

Texas College Lecturer Charged with Manufacturing and Selling Counterfeit Adderall

December 19, 2019

Authorities seized close to 40,000 fake Adderall pills from Rodriguez-Rabin’s apartment. There was also a “machine to make the pills” seized during the raid. Rodriguez-Rabin is a 51-year-old lecturer that worked in the University of Texas system.

Read More

HHS Announces Dangerous Draft Regulations for Importing Drugs from Canada

December 18, 2019

Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…

Read More